Evidence map›Paper›PMID 25118328›Full record

ArticleScience signaling2014

Type IV collagen is an activating ligand for the adhesion G protein-coupled receptor GPR126.

Kevin J Paavola, Harwin Sidik, J Bradley Zuchero, Michael Eckart, William S Talbot

Open access · greenAbstract read
In one paragraph

Article in Science signaling, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 108 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
108citing papers in PubMed, 1 pooled it
9.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

108 citing papers in PubMed, 1 synthesis or guideline pooled it, 188 citations in OpenAlex.

  1. Pooled it
  2. Ryanodine receptor cluster remodeling linksbioRxiv : the preprint server for biology · 2026
    Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Adhesion G protein-coupled receptors.Pharmacological reviews · 2026
    Review
  8. Article
  9. The far extracellular CUB domain of the adhesion GPCR ADGRG6/GPR126 is a key regulator of receptor signaling.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Schwann Cell Development and Myelination.Cold Spring Harbor perspectives in biology · 2024
    Review
  19. Article
  20. Article

48 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Kevin J PaavolaDepartment of Developmental Biology, Stanford University School of Medicine, Stanford, CA 94305, USA.
Harwin SidikDepartment of Developmental Biology, Stanford University School of Medicine, Stanford, CA 94305, USA.
J Bradley ZucheroDepartment of Neurobiology, Stanford University School of Medicine, Stanford, CA 94305, USA.
Michael EckartProtein and Nucleic Acid Facility, Stanford University School of Medicine, Stanford, CA 94035, USA.
William S TalbotDepartment of Developmental Biology, Stanford University School of Medicine, Stanford, CA 94305, USA. wtalbot@stanford.edu.
Stanford University · US

Funding

Genetics Mechanisms of Myelination in ZebrafishR01NS050223 · NINDS · STANFORD UNIVERSITY · PI TALBOT, WILLIAM S · 2004 to 2018
$4.9M
Genetic mechanisms of myelination in zebrafishR56NS050223 · NINDS · STANFORD UNIVERSITY · PI TALBOT, WILLIAM S · 2008 to 2008
$390k
Howard Hughes Medical InstituteNINDS NIH HHS NS050223NINDS NIH HHS R01 NS050223NINDS NIH HHS R56 NS050223
6 · The paper itself

Abstract

GPR126 is an orphan heterotrimeric guanine nucleotide-binding protein (G protein)-coupled receptor (GPCR) that is essential for the development of diverse organs. We found that type IV collagen, a major constituent of the basement membrane, binds to Gpr126 and activates its signaling function. Type IV collagen stimulated the production of cyclic adenosine monophosphate in rodent Schwann cells, which require Gpr126 activity to differentiate, and in human embryonic kidney (HEK) 293 cells expressing exogenous Gpr126. Type IV collagen specifically bound to the extracellular amino-terminal region of Gpr126 containing the CUB (complement, Uegf, Bmp1) and pentraxin domains. Gpr126 derivatives lacking the entire amino-terminal region were constitutively active, suggesting that this region inhibits signaling and that ligand binding relieves this inhibition to stimulate receptor activity. A new zebrafish mutation that truncates Gpr126 after the CUB and pentraxin domains disrupted development of peripheral nerves and the inner ear. Thus, our findings identify type IV collagen as an activating ligand for GPR126, define its mechanism of activation, and highlight a previously unrecognized signaling function of type IV collagen in basement membranes.

Indexed as

AnimalsBiotinylationCell AdhesionCloning, MolecularCollagen Type IVCyclic AMPDNA PrimersEar, InnerGene ComponentsGenetic VectorsHEK293 CellsHumansMutationMyelin SheathProtein BindingProtein Structure, TertiaryADGRG6 protein, humanCollagen Type IVCyclic AMPDNA PrimersReceptors, G-Protein-Coupled

Identifiers

PMID25118328
PMCPMC4159047
OpenAlexW2153225946

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.